Two Limited-Time Offers from Dexcom

1 CGM-based treatment requires fingersticks for calibration; may result in hypoglycemia if calibration not performed, when taking acetaminophen, or if symptoms/expectations do not match CGM readings.
2 Touch Simplicity Today Pump Access Program https://www.tandemdiabetes.com/landing-pages/touch-simplicity-terms-and-conditions
3 This Welcome Program is available to Animas® insulin pump users only. Proof of ownership is required. To qualify, insurance coverage must be verified. The Welcome Program excludes beneficiaries of Medicare, Medicaid, Tricare and any other federal or state funded health insurance program. Patients whose private insurance precludes it are also excluded from this Welcome Program. Users who are residents of MA, MI, MN, and RI are also excluded. Valid credit card information must be provided up front. Credit card will be charged at first product shipment after The Welcome Program order. Welcome Program terms and conditions subject to change. Welcome Program available if you enroll by April 31, 2018. Under the terms of this Welcome Program, the limited warranty period for the Personal Diabetes Manager (PDM) will be the longer of: two years from your date of order from Insulet, or the remainder of your existing insulin pump warranty, not to exceed 4 years from your date of order from Insulet. Insulet will not charge your insurance and you agree to not seek reimbursement for the PDM or free Pods obtained under this special Welcome Program. To take advantage of The Welcome Program, please call 888-6-GETPOD. Other restrictions may apply.

BRIEF SAFETY STATEMENT The Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System (“G5”) is a glucose monitoring system indicated for the management of diabetes in persons age 2 years and older. The G5 is designed to replace fingerstick blood glucose testing for diabetes treatment decisions. The G5 also aids in the detection of episodes of hyperglycemia and hypoglycemia. The G5 is intended for single patient use and requires a prescription. CONTRAINDICATIONS Do not rely on the G5 CGM data if you have recently taken acetaminophen. Remove the G5 (sensor, transmitter, and receiver) before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or high-frequency electrical heat (diathermy) treatment. The G5 is MR Unsafe. Do not bring any portion of the G5 into the MRI environment. WARNING CGM-based diabetes treatment decisions are only approved with the G5, not previous generations of Dexcom CGM systems. Calibrate at least once every 12 hours using a fingerstick. If your G5 does not display a sensor glucose reading and an arrow, or if you are getting inaccurate or inconsistent readings, take a fingerstick. If your glucose readings and alerts do not match your symptoms or expectations, take a fingerstick to confirm. Failure to do so may lead to hyperglycemia or hypoglycemia. The G5 is not approved for use in pregnant women, persons on dialysis or critically ill persons. If a sensor breaks and no portion of it is visible above the skin, do not attempt to remove it. Seek professional medical help if you have infection or inflammation on or near the sensor insertion point. Report broken sensors to Dexcom Technical Support. Sensor placement is not approved for sites other than under the skin of the belly (ages 2 years and older) or upper buttocks (ages 2-17 years). To “share” data, you need an internet connection and a separate compatible smart device running the Dexcom Follow App. Contact Dexcom Toll Free at 877-339-2664 or www.dexcom.com for detailed indications for use and safety information.

*Special Instructions:
PATIENT SURVEY PROGRAM: This Program is available to eligible patients who upgrade from Dexcom G4 to Dexcom G5 Mobile between October 16 – March  31, 2018 (with Tandem) or October 16 – January 31, 2018 (with Omnipod) or new patients who purchase a Dexcom G5 CGM System from Dexcom directly at www.dexcom.com or through a Dexcom authorized distributor, (b) complete the Dexcom patient survey, AND (c) get started with Omnipod between October 16 – January 31, 2018 or Tandem between October 16 – March 31, 2018. Purchase of the Dexcom G5 and the Omnipod must be made no earlier than October 16, 2017 and no later than January 31, 2018; purchase of the Dexcom G5 and Tandem t:slim X2 must be made no earlier than October 16 and no later than March 31, 2018 and must be paid for in full. This Program provides to the new patient qualifying for this Program and completing the survey a payment of $200 in the form of a MasterCard or VISA gift card. To obtain the payment, a patient must visit www.dexcom.com/omnipod or www.dexcom.com/tandem and provide name, email, mailing address, date of birth and serial number for their Dexcom G5 transmitter and Omnipod or Tandem pump. By requesting a payment under this Program, you are certifying that you meet the eligibility criteria and will comply with the terms and conditions described in the Eligibility and Restrictions section below, and agreeing to the use of your information consistent with Dexcom’s Privacy Policy and the terms of the survey. Patients with questions about this Program should call 855-977-1950. 

Terms & Conditions:
Eligibility and Restrictions: Valid for all patients other than the following who are not eligible for this Program:

• Individuals covered in any part by Medicaid, Medicare, Tricare, or any other federal or state health care programs (such as medical assistance programs);
• Members of a Kaiser Permanente Health Plan, and any other health plan or insurance contract that prohibits this Program;
• Residents of Massachusetts and South Dakota and any other state where prohibited by law;
• Persons residing outside the United States and Puerto Rico;
• Eligibility period is for purchases made between October 16- January 31, 2018 (with Omnipod) or October 16- March 31, 2018 (with Tandem). Must provide proof of purchase and complete patient survey by February 15, 2018 (Omni pod) and April 30, 2018 (Tandem).
• Offer not valid to patients who return Dexcom G5 product within 30 days of purchase.

By participating in this Program, the patient certifies that he or she will comply with the terms of the patient’s health insurance contract, including but not limited to those requiring notification to the payor of the existence or value of this Program. Limit 1 offer per patient. It is illegal to (or offer to) sell, purchase, or trade this offer. This promotion is not transferable and cannot be combined with any other programs, offers or discounts. Void where prohibited by law or taxed or restricted. Program managed by Afligo, on behalf of Dexcom. Redemptions to be fully processed within 10-12 weeks. Dexcom reserves the right to rescind, revoke or amend this offer without notice at any time. © 2017 Dexcom Inc. All rights reserved. This product is covered by U.S. patent.